NuStar GP (NYSE:NSH) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Saturday.
According to Zacks, “NUSTAR GP HOLDINGS is a publicly traded limited liability company that owns the two percent general partner interest, a 18.4 percent limited partner interest and the incentive distribution rights in NuStar Energy L.P.They are one of the largest asphalt refiners and marketers and independent terminal and petroleum liquids pipeline operators in the nation with operations in the United States, Netherlands Antilles, Canada, Mexico, the Netherlands and the United Kingdom. “
Other equities analysts have also issued reports about the company. Mizuho set a $16.00 target price on NuStar GP and gave the stock a “hold” rating in a research report on Friday, February 9th. Citigroup lowered NuStar GP from a “buy” rating to a “neutral” rating in a research report on Friday, February 2nd. ValuEngine lowered NuStar GP from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. B. Riley started coverage on NuStar GP in a research report on Friday, January 26th. They issued a “buy” rating and a $20.00 price target for the company. Finally, Barclays lowered their price target on NuStar GP from $22.00 to $21.00 and set an “equal weight” rating for the company in a research report on Wednesday, November 8th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and two have issued a buy rating to the company. NuStar GP presently has an average rating of “Hold” and an average target price of $20.50.
NuStar GP (NYSE:NSH) opened at $12.95 on Friday. NuStar GP has a 12-month low of $12.51 and a 12-month high of $30.60. The firm has a market capitalization of $556.24, a P/E ratio of 6.44 and a beta of 1.02.
NuStar GP (NYSE:NSH) last issued its earnings results on Thursday, February 8th. The pipeline company reported $0.17 earnings per share for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.12). NuStar GP had a return on equity of 23.49% and a net margin of 168.31%. The firm had revenue of $10.30 million for the quarter, compared to analyst estimates of $12.68 million. equities research analysts predict that NuStar GP will post 1.42 EPS for the current fiscal year.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. BNP Paribas Arbitrage SA purchased a new stake in NuStar GP in the 3rd quarter valued at $103,000. Covenant Multifamily Offices LLC purchased a new stake in NuStar GP in the 4th quarter valued at $131,000. Raymond James & Associates purchased a new stake in NuStar GP in the 4th quarter valued at $168,000. Alliancebernstein L.P. raised its position in NuStar GP by 5.9% in the 2nd quarter. Alliancebernstein L.P. now owns 8,841 shares of the pipeline company’s stock valued at $216,000 after buying an additional 495 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership purchased a new stake in NuStar GP in the 2nd quarter valued at $237,000. 58.70% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: “NuStar GP (NSH) Downgraded by Zacks Investment Research to Hold” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/19/nustar-gp-nsh-downgraded-by-zacks-investment-research-to-hold-2.html.
About NuStar GP
NuStar GP Holdings, LLC holds interests in NuStar Energy L.P. (NuStar Energy). NuStar Energy is engaged in the transportation of petroleum products and anhydrous ammonia, the terminalling and storage of petroleum products and the marketing of petroleum products. NuStar Energy has terminal and storage facilities in the United States, Canada, Mexico, the Netherlands, including St.
Get a free copy of the Zacks research report on NuStar GP (NSH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for NuStar GP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NuStar GP and related companies with MarketBeat.com's FREE daily email newsletter.